Anti-SLC17A9 monoclonal antibody

Pre-made anti-SLC17A9 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC17A9/SLC17A9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1656-Ab-1/ GM-Tg-hg-IP1656-Ab-2Anti-Human SLC17A9 monoclonal antibodyHuman
GM-Tg-rg-IP1656-Ab-1/ GM-Tg-rg-IP1656-Ab-2Anti-Rat SLC17A9 monoclonal antibodyRat
GM-Tg-mg-IP1656-Ab-1/ GM-Tg-mg-IP1656-Ab-2Anti-Mouse SLC17A9 monoclonal antibodyMouse
GM-Tg-cynog-IP1656-Ab-1/ GM-Tg-cynog-IP1656-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC17A9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1656-Ab-1/ GM-Tg-felg-IP1656-Ab-2Anti-Feline SLC17A9 monoclonal antibodyFeline
GM-Tg-cang-IP1656-Ab-1/ GM-Tg-cang-IP1656-Ab-2Anti-Canine SLC17A9 monoclonal antibodyCanine
GM-Tg-bovg-IP1656-Ab-1/ GM-Tg-bovg-IP1656-Ab-2Anti-Bovine SLC17A9 monoclonal antibodyBovine
GM-Tg-equg-IP1656-Ab-1/ GM-Tg-equg-IP1656-Ab-2Anti-Equine SLC17A9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1656-Ab-1/ GM-Tg-hg-IP1656-Ab-2; GM-Tg-rg-IP1656-Ab-1/ GM-Tg-rg-IP1656-Ab-2;
GM-Tg-mg-IP1656-Ab-1/ GM-Tg-mg-IP1656-Ab-2; GM-Tg-cynog-IP1656-Ab-1/ GM-Tg-cynog-IP1656-Ab-2;
GM-Tg-felg-IP1656-Ab-1/ GM-Tg-felg-IP1656-Ab-2; GM-Tg-cang-IP1656-Ab-1/ GM-Tg-cang-IP1656-Ab-2;
GM-Tg-bovg-IP1656-Ab-1/ GM-Tg-bovg-IP1656-Ab-2; GM-Tg-equg-IP1656-Ab-1/ GM-Tg-equg-IP1656-Ab-2
Products NameAnti-SLC17A9 monoclonal antibody
Formatmab
Target NameSLC17A9
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC17A9 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1656-Ag-1Recombinant multi-species S17A9/ SLC17A9/ C20orf59 protein


    Target information

    Target IDGM-IP1656
    Target NameSLC17A9
    Gene ID63910,228993,362287,698062,485966,101081131,518062,100058964
    Gene Symbol and Synonyms1700019H03Rik,C13H20ORF59,C20orf59,POROK8,RGD1311940,SLC17A9,VNUT
    Uniprot AccessionQ9BYT1
    Uniprot Entry NameS17A9_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000101194
    Target ClassificationN/A

    The target: SLC17A9, gene name: SLC17A9, also named as C20orf59, POROK8, VNUT. This gene encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. The encoded protein participates in the vesicular uptake, storage, and secretion of adenoside triphosphate (ATP) and other nucleotides. A mutation in this gene was found in individuals with autosomal dominant disseminated superficial actinic porokeratosis-8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.